Cargando…

Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data

BACKGROUND: Accurate TNM stage information is essential for cancer health services research, but is often impractical and expensive to collect at the population-level. We evaluated algorithms using administrative healthcare data to identify patients with metastatic gastric cancer. METHODS: A populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahar, Alyson L., Jeong, Yunni, Zagorski, Brandon, Coburn, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930789/
https://www.ncbi.nlm.nih.gov/pubmed/29716600
http://dx.doi.org/10.1186/s12913-018-3125-7
_version_ 1783319539202654208
author Mahar, Alyson L.
Jeong, Yunni
Zagorski, Brandon
Coburn, Natalie
author_facet Mahar, Alyson L.
Jeong, Yunni
Zagorski, Brandon
Coburn, Natalie
author_sort Mahar, Alyson L.
collection PubMed
description BACKGROUND: Accurate TNM stage information is essential for cancer health services research, but is often impractical and expensive to collect at the population-level. We evaluated algorithms using administrative healthcare data to identify patients with metastatic gastric cancer. METHODS: A population-based cohort of gastric cancer patients diagnosed between 2005 and 2007 identified from the Ontario Cancer Registry were linked to routinely collected healthcare data. Reference standard data identifying metastatic disease were obtained from a province-wide chart review, according to the Collaborative Staging method. Algorithms to identify metastatic gastric cancer were created using administrative healthcare data from hospitalization, emergency department, and physician billing records. Time frames of data collection in the peri-diagnosis period, and the diagnosis codes used to identify metastatic disease were varied. Algorithm sensitivity, specificity, and accuracy were evaluated. RESULTS: Of 2366 gastric cancer patients, included within the chart review, 54.3% had metastatic disease. Algorithm sensitivity ranged from 50.0- 90%, specificity ranged from 27.6 - 92.5%, and accuracy from 61.5 - 73.4%. Sensitivity and specificity were maximized when the most conservative list of diagnosis codes from hospitalization and outpatient records in the six months prior to and the six months following diagnosis were included. CONCLUSION: Algorithms identifying metastatic gastric cancer can be used for research purposes using administrative healthcare data, although they are imperfect measures. The properties of these algorithms may be generalizable to other high fatality cancers and other healthcare systems. This study provides further support for the collection of population-based, TNM stage data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3125-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5930789
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59307892018-05-09 Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data Mahar, Alyson L. Jeong, Yunni Zagorski, Brandon Coburn, Natalie BMC Health Serv Res Research Article BACKGROUND: Accurate TNM stage information is essential for cancer health services research, but is often impractical and expensive to collect at the population-level. We evaluated algorithms using administrative healthcare data to identify patients with metastatic gastric cancer. METHODS: A population-based cohort of gastric cancer patients diagnosed between 2005 and 2007 identified from the Ontario Cancer Registry were linked to routinely collected healthcare data. Reference standard data identifying metastatic disease were obtained from a province-wide chart review, according to the Collaborative Staging method. Algorithms to identify metastatic gastric cancer were created using administrative healthcare data from hospitalization, emergency department, and physician billing records. Time frames of data collection in the peri-diagnosis period, and the diagnosis codes used to identify metastatic disease were varied. Algorithm sensitivity, specificity, and accuracy were evaluated. RESULTS: Of 2366 gastric cancer patients, included within the chart review, 54.3% had metastatic disease. Algorithm sensitivity ranged from 50.0- 90%, specificity ranged from 27.6 - 92.5%, and accuracy from 61.5 - 73.4%. Sensitivity and specificity were maximized when the most conservative list of diagnosis codes from hospitalization and outpatient records in the six months prior to and the six months following diagnosis were included. CONCLUSION: Algorithms identifying metastatic gastric cancer can be used for research purposes using administrative healthcare data, although they are imperfect measures. The properties of these algorithms may be generalizable to other high fatality cancers and other healthcare systems. This study provides further support for the collection of population-based, TNM stage data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3125-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-02 /pmc/articles/PMC5930789/ /pubmed/29716600 http://dx.doi.org/10.1186/s12913-018-3125-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mahar, Alyson L.
Jeong, Yunni
Zagorski, Brandon
Coburn, Natalie
Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data
title Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data
title_full Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data
title_fullStr Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data
title_full_unstemmed Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data
title_short Validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected TNM staging data
title_sort validating an algorithm to identify metastatic gastric cancer in the absence of routinely collected tnm staging data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930789/
https://www.ncbi.nlm.nih.gov/pubmed/29716600
http://dx.doi.org/10.1186/s12913-018-3125-7
work_keys_str_mv AT maharalysonl validatinganalgorithmtoidentifymetastaticgastriccancerintheabsenceofroutinelycollectedtnmstagingdata
AT jeongyunni validatinganalgorithmtoidentifymetastaticgastriccancerintheabsenceofroutinelycollectedtnmstagingdata
AT zagorskibrandon validatinganalgorithmtoidentifymetastaticgastriccancerintheabsenceofroutinelycollectedtnmstagingdata
AT coburnnatalie validatinganalgorithmtoidentifymetastaticgastriccancerintheabsenceofroutinelycollectedtnmstagingdata